On Monday, E*TRADE Financial Corp (NASDAQ:ETFC)’s shares inclined 1.55% to $29.49.
E*TRADE Financial Corp (ETFC) stated a fall in its Daily Average Revenue Trades (DARTs) for May 2015. According to the monthly market activity report for May, E*TRADE’s DARTs totaled 151,444, down 4% from the prior month and up 3% on a year-over-year basis.
Broker performance is generally measured through DARTs that represent the number of trades from which brokers can expect commissions or fees. The fall in DARTs largely reflects investors’ unwillingness to invest in equity markets.
At the end of the month under review, E*TRADE had about 4.8 million accounts – 3.2 million brokerage accounts, 1.3 million stock plan accounts and 0.3 million banking accounts.
For the stated month, E*TRADE’s total brokerage accounts comprised of 27,865 gross new brokerage accounts. Moreover, the company’s net new brokerage assets totaled $1.0 billion contrast with negative $0.4 billion recorded in the prior month. Total brokerage accounts reflect the company’s ability to attract and retain customers who trade and invest.
E*TRADE Financial Corporation, a financial services company, provides brokerage and related products and services primarily to individual retail investors under the E*TRADE Financial brand name. It operates through two segments, Trading and Investing, and Balance Sheet Administration.
International Paper Co (NYSE:IP)’s shares gained 1.83% to $47.80.
International Paper (IP) will release second-quarter 2015 earnings on Wednesday, July 29, 2015 before the opening of the New York Stock Exchange. The company will host a webcast to talk about earnings and current market conditions, starting at 9 a.m. ET (8 a.m. CT). All interested parties are invited to listen to the webcast via the company’s Internet site at http://www.internationalpaper.com by clicking on the Investors tab and going to the Webcasts and Presentations page. A replay of the webcast will also be on the web site starting about two hours after the call.
International Paper Company operates as a paper and packaging company in North America, Europe, Latin America, Russia, Asia, Africa, and the Middle East. The company operates through three segments: Industrial Packaging, Printing Papers, and Consumer Packaging. The Industrial Packaging segment manufactures containerboards, counting linerboard, medium, whitetop, recycled linerboard, recycled medium, and saturating kraft. The Printing Papers segment produces printing and writing papers, such as uncoated papers for end use applications, counting brochures, pamphlets, greeting cards, books, annual reports, and direct mail, in addition to envelopes, tablets, business forms, and file folders. This segment sells uncoated papers under the Hammermill, Springhill, Williamsburg, Postmark, Accent, Great White, Chamex, Ballet, Rey, Pol, and Svetocopy brand names. It also produces pulp for manufacturing printing, writing, and specialty papers, in addition to towels and tissues, filtration products, diapers, and sanitary napkins.
At the end of Monday’s trade, Sequenom, Inc. (NASDAQ:SQNM)‘s shares surged 7.80% to $3.18.
Sequenom, Inc. (SQNM) a life sciences company committed to enabling healthier lives through the development of innovative products and services, announced today the upcoming launch of the MaterniT™ GENOME laboratory-developed test. This test is the first noninvasive prenatal test (NIPT) to provide karyotype-level insight into fetal chromosomal status prior to considering an invasive procedure. The MaterniT GENOME test adds genome-wide identification of chromosomal gains or losses greater than 7 megabases (Mb) in size to Sequenom Laboratories’ growing NIPT testing portfolio.
The MaterniT GENOME test builds upon the industry leading microdeletion performance demonstrated by Sequenom Laboratories with the MaterniT21 PLUS laboratory-developed test, which was recently highlighted in an article by Hume JH, et al, published in the peer-reviewed journal Prenatal Diagnosis. Data supporting the validation of the MaterniT GENOME test will be presented at the 19th International Conference on Prenatal Diagnosis and Treatment (sponsored by the International Society of Prenatal Diagnosis and Therapy - ISPD) in Washington D.C., taking place July 12-15, 2015. The MaterniT GENOME test will be accessible to physicians later this quarter.
Sequenom, Inc., a life sciences company, develops and commercializes molecular diagnostics testing services for the women’s health and oncology markets in the United States and internationally. The company provides molecular based laboratory developed tests (LDTs) comprising MaterniT21 PLUS LDT, a noninvasive prenatal test (NIPT) to detect fetal chromosomal abnormalities; HerediT CF LDT, a carrier screen test to identify individuals with cystic fibrosis or genetic mutations; SensiGene fetal Rhesus D (RhD) LDT, a NIPT to determine the presence or absence of RhD factor by direct detection of the fetal RhD genotype in RhD negative mothers from a maternal blood sample; and VisibiliT LDT, a NIPT to detect fetal chromosomal abnormalities by determining the relative amount of chromosomal material present in circulating cell-free DNA in a maternal blood sample.
Nike Inc (NYSE:NKE), ended its Monday’s trading session with 1.73% gain, and closed at $12.43.
NIKE, Inc. (NKE) and its Chairman, Phil Knight, recently declared actions that will provide long-term stability in the ownership and governance of the company counting transfer of ownership of Phil Knight’s shares to a Limited Liability Company.
Concurrent with recently declarement, Knight and the NIKE Board of Directors also declared the start of a succession planning process that will conclude in the appointment of NIKE’s next Chairman. Knight has informed the NIKE Board of Directors of his recommendation to have Mark Parker, NIKE’s President and Chief Executive Officer since 2006, succeed him as Chairman. Further, the Company also named Travis Knight as the newest member of NIKE’s Board of Directors.
NIKE, Inc., together with its auxiliaries, designs, develops, markets, and sells athletic footwear, apparel, equipment, and accessories for men, women, and kids worldwide. The company offers products in eight categories, counting running, basketball, football, men’s training, women’s training, sportswear, action sports, and golf under the NIKE and Jordan brand names.
DISCLAIMER:
This article is published by www.wsnewspublishers.com. The Content included in this article is just for informational purposes only. All information used in this article is believed to be from reliable sources, but we make no representations or warranties of any kind, express or implied, about the completeness, accuracy, or reliability with respect to this article.
All visitors are advised to conduct their own independent research into individual stocks before making a purchase decision.
Information contained in this article contains forward-looking information within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, counting statements regarding the predictable continual growth of the market for the corporation’s products, the corporation’s ability to fund its capital requirement in the near term and in the long term; pricing pressures; etc.
Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, aims, assumptions, or future events or performance may be forward looking statements. Forward-looking statements are based on expectations, estimates, and projections at the time the statements are made that involve a number of risks and uncertainties which could cause actual results or events to differ materially from those presently anticipated. Forward looking statements may be identified through the use of such words as expects, will, anticipates, estimates, believes, or by statements indicating certain actions may, could, should might occur.
